Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness

BACKGROUND: There is no consensus on the most effective strategy (mammography or magnetic resonance imaging (MRI)) for screening women with BRCA1 or BRCA2 mutations. The effectiveness and cost-effectiveness of the Dutch, UK and US screening strategies, which involve mammography and MRI at different...

Descripción completa

Detalles Bibliográficos
Autores principales: de Bock, G H, Vermeulen, K M, Jansen, L, Oosterwijk, J C, Siesling, S, Dorrius, M D, Feenstra, T, Houssami, N, Greuter, M J W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668482/
https://www.ncbi.nlm.nih.gov/pubmed/23579217
http://dx.doi.org/10.1038/bjc.2013.149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668482/
https://www.ncbi.nlm.nih.gov/pubmed/23579217
http://dx.doi.org/10.1038/bjc.2013.149

Ejemplares similares